1. Home
  2. HTD vs DNA Comparison

HTD vs DNA Comparison

Compare HTD & DNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HTD
  • DNA
  • Stock Information
  • Founded
  • HTD 2004
  • DNA 2008
  • Country
  • HTD United States
  • DNA United States
  • Employees
  • HTD N/A
  • DNA N/A
  • Industry
  • HTD Finance Companies
  • DNA Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • HTD Finance
  • DNA Health Care
  • Exchange
  • HTD Nasdaq
  • DNA Nasdaq
  • Market Cap
  • HTD 868.1M
  • DNA 731.1M
  • IPO Year
  • HTD N/A
  • DNA N/A
  • Fundamental
  • Price
  • HTD $24.36
  • DNA $11.08
  • Analyst Decision
  • HTD
  • DNA Hold
  • Analyst Count
  • HTD 0
  • DNA 2
  • Target Price
  • HTD N/A
  • DNA $9.50
  • AVG Volume (30 Days)
  • HTD 92.3K
  • DNA 1.6M
  • Earning Date
  • HTD 01-01-0001
  • DNA 11-11-2025
  • Dividend Yield
  • HTD 8.59%
  • DNA N/A
  • EPS Growth
  • HTD N/A
  • DNA N/A
  • EPS
  • HTD N/A
  • DNA N/A
  • Revenue
  • HTD N/A
  • DNA $230,815,000.00
  • Revenue This Year
  • HTD N/A
  • DNA N/A
  • Revenue Next Year
  • HTD N/A
  • DNA $14.41
  • P/E Ratio
  • HTD N/A
  • DNA N/A
  • Revenue Growth
  • HTD N/A
  • DNA 25.21
  • 52 Week Low
  • HTD $16.17
  • DNA $5.00
  • 52 Week High
  • HTD $22.13
  • DNA $16.85
  • Technical
  • Relative Strength Index (RSI)
  • HTD 46.21
  • DNA 47.46
  • Support Level
  • HTD $24.45
  • DNA $9.87
  • Resistance Level
  • HTD $24.70
  • DNA $11.97
  • Average True Range (ATR)
  • HTD 0.17
  • DNA 0.80
  • MACD
  • HTD -0.04
  • DNA -0.09
  • Stochastic Oscillator
  • HTD 24.47
  • DNA 37.64

About HTD John Hancock Tax Advantaged Dividend Income Fund of Beneficial Interest

John Hancock Tax-advantaged Div Inc Fd is a closed-end, diversified management investment company. Its investment objective is to provide a high after-tax total return from dividend income and capital appreciation. The fund's portfolio composition consists of common stocks, preferred securities, corporate bonds, convertible bonds, and short-term investments. Its sector composition comprises utilities, financials, energy, telecommunication services, industrials, healthcare, real estate, consumer discretionary and short-term investments.

About DNA Ginkgo Bioworks Holdings Inc.

Ginkgo Bioworks Holdings Inc is the platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. The Company reorganized its operations into two operating and reportable segments: Cell Engineering: where company provide biological R&D services for customers across a range of industries and Biosecurity: where it provide services to government and commercial customers to identify, monitor, prevent, mitigate, and ultimately protect humanity from biological threats. The maximum of revenue is from Cell Engineering Segment.

Share on Social Networks: